Selected article for: "markedly increase and present study"

Author: Nordén, Rickard; Magnusson, Jesper; Lundin, Anna; Tang, Ka-Wei; Nilsson, Staffan; Lindh, Magnus; Andersson, Lars-Magnus; Riise, Gerdt C; Westin, Johan
Title: Quantification of Torque Teno Virus and Epstein-Barr Virus Is of Limited Value for Predicting the Net State of Immunosuppression After Lung Transplantation
  • Document date: 2018_3_6
  • ID: zhlvvuj4_44
    Snippet: In the present study, mean EBV-DNA levels did not increase as markedly as TTV-DNA levels after transplantation, even though EBV-specific T cells most likely are subverted by immunosuppressive therapy [43] . The seroprevalence pre-LTx and number of patients positive for EBV-DNA at any time during FU were comparable to previous studies [24, 42, 44] . One possible caveat when determining EBV DNA load is the use of valgangciclovir for preventing reac.....
    Document: In the present study, mean EBV-DNA levels did not increase as markedly as TTV-DNA levels after transplantation, even though EBV-specific T cells most likely are subverted by immunosuppressive therapy [43] . The seroprevalence pre-LTx and number of patients positive for EBV-DNA at any time during FU were comparable to previous studies [24, 42, 44] . One possible caveat when determining EBV DNA load is the use of valgangciclovir for preventing reactivation or primary infection of CMV. All patients received 3 months of valgangciclovir treatment initially after LTx; there are a few studies showing that valgangciclovir treatment reduces EBV load, which may have affected the results in this study [45, 46] .

    Search related documents:
    Co phrase search for related documents
    • CMV primary infection reactivation and primary infection reactivation: 1
    • dna load and EBV DNA level: 1
    • dna load and EBV dna load: 1, 2, 3, 4
    • dna load and EBV load: 1, 2, 3, 4
    • dna load and immunosuppressive therapy: 1
    • dna load and present study: 1, 2, 3
    • dna load and primary infection: 1
    • dna load and TTV dna: 1, 2, 3, 4
    • EBV DNA level and pre LTx: 1
    • EBV DNA level and TTV dna: 1
    • EBV dna load and TTV dna: 1, 2
    • EBV load and present study: 1
    • EBV load and TTV dna: 1, 2
    • immunosuppressive therapy and patient number: 1, 2
    • immunosuppressive therapy and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • immunosuppressive therapy and previous study: 1, 2, 3, 4
    • immunosuppressive therapy and primary infection: 1, 2, 3, 4, 5, 6
    • immunosuppressive therapy and TTV dna: 1, 2, 3
    • immunosuppressive therapy and TTV dna level: 1